Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Two Markman Victories..does .14 cents per share seem even remotely appropriate?

I think we have to remember that we only own 50% of the MMP, thus the market values we see are actually twice that. IMO of course.

Share
New Message
Please login to post a reply